The Iliac/SFA/Popliteal Center

Filter Your Results




Dynamic Forces in the SFA and Popliteal Artery During Knee Flexion

Frederik H.W. Jonker, MS; Felix J.V. Schlösser, MD; Frans L. Moll, MD, PhD; and Bart E. Muhs, MD, PhD

May 2008—Consequences of stress to consider for stent durability and design.

Tackling Popliteal Artery Lesions

Subhash Banerjee, MD; Emmanouil S. Brilakis, MD, PhD; and Tony S. Das, MD

May 2008—Today's devices enable lesion-specific care tailored to each patient.

Treating Complex SFA Occlusive Disease

Donald T. Baril, MD; Luke K. Marone, MD; and Mark H. Wholey, MD

April 2008—Two case reports detailing the use of the Viabahn endoprosthesis with heparin bioactive surface.

An Interview with Marc Bosiers, MD

February 2008—A vascular surgeon and leader in endovascular research discusses the next generation of peripheral stents, drug-coated balloons, and the progress of carotid stenting.

In-Stent Restenosis of the SFA

Soo Rhee, MD, and James F. McKinsey, MD

April 2007—Two case studies using a retrograde approach with a combination of different devices to treat recurrent lower-extremity ischemia.

Difficult Access for a CTO in the SFA

Tony S. Das, MD, FACC

April 2007—Alternative options for accessing and treating this challenging but common indication.

Endograft Treatment in the SFA

Mark W. Mewissen, MD

February 2007—Current SFA stent graft technology has overcome early shortcomings and carries the potential to become the standard of care in selected patients.

A 2007 Update on Treating Nitinol Stent Restenosis

Gary M. Ansel, MD, FACC; Charles F. Botti, Jr, MD; Melinda Taylor, RN; and Mitchell J. Silver, DO

February 2007—Using Viabahn covered stents to treat restenosis in the superficial femoral artery.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.